The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Targeting the mitochondrial cell death pathway with gold compounds
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
N-Heterocyclic Carbenes: A New Concept in Organometallic Catalysis
Herrmann, W. A. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020415)41:8<1290::aid-anie1290>3.0.co;2-y · Cited by 3,769
Bourissou, D., Guerret, O., Gabbaï, F. P., & Bertrand, G. (2000) · Chemical Reviews · doi:10.1021/cr940472u · Cited by 3,633
Scholl, M., Ding, S., Lee, C. W., & Grubbs, R. H. (1999) · Organic Letters · doi:10.1021/ol990909q · Cited by 3,467
The Pathophysiology of Mitochondrial Cell Death
Green, D. R., & Kroemer, G. (2004) · Science · doi:10.1126/science.1099320 · Cited by 3,418
Physiological functions of thioredoxin and thioredoxin reductase
Arnér, E. S. J., & Holmgren, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01701.x · Cited by 2,525
The mitochondrial permeability transition pore and its role in cell death
CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432
Mitochondria as the central control point of apoptosis
Desagher, S., & Martinou, J.-C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01803-1 · Cited by 1,913
Mitochondrial Membrane Potential in Living Cells
Chen, L. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001103 · Cited by 1,037
The permeability transition pore complex: another view
Halestrap, A. P., McStay, G. P., & Clarke, S. J. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01375-5 · Cited by 709
Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells
Modica-Napolitano, J. S., & Aprille, J. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00125-9 · Cited by 576
Mitochondria as a Pharmacological Target
Szewczyk, A., & Wojtczak, L. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.101 · Cited by 538
Human Placenta Thioredoxin Reductase
Gromer, S., Arscott, L. D., Williams, C. H., Schirmer, R. H., & Becker, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20096 · Cited by 536
Mitochondrion as a Novel Target of Anticancer Chemotherapy
Costantini, P. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.13.1042 · Cited by 532
Ross, M. F., Kelso, G. F., Blaikie, F. H., James, A. M., Cochemé, H. M., Filipovska, A., Da Ros, T., Hurd, T. R., Smith, R. A. J., & Murphy, M. P. (2005) · Biochemistry (Moscow) · doi:10.1007/s10541-005-0104-5 · Cited by 493
Mitochondria, the killer organelles and their weapons
Ravagnan, L., Roumier, T., & Kroemer, G. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10111 · Cited by 483
Mitochondrial regulation of apoptotic cell death
Orrenius, S. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.017 · Cited by 481
The thioredoxin system—From science to clinic
Gromer, S., Urig, S., & Becker, K. (2004) · Medicinal Research Reviews · doi:10.1002/med.10051 · Cited by 479
Stabilization of Organometallic Species Achieved by the Use of N‐Heterocyclic Carbene (NHC) Ligands
Scott, N. M., & Nolan, S. P. (2005) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200500030 · Cited by 460
Chemotherapy: targeting the mitochondrial cell death pathway
Debatin, K.-M., Poncet, D., & Kroemer, G. (2002) · Oncogene · doi:10.1038/sj.onc.1206039 · Cited by 396
Thioredoxin reductase as a pathophysiological factor and drug target
Becker, K., Gromer, S., Schirmer, R. H., & Müller, S. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01703.x · Cited by 388
Selective targeting of bioactive compounds to mitochondria
Murphy, M. P. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01068-8 · Cited by 366
Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells.
Summerhayes, I. C., Lampidis, T. J., Bernal, S. D., Nadakavukaren, J. J., Nadakavukaren, K. K., Shepherd, E. L., & Chen, L. B. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.17.5292 · Cited by 366
Mansour, M. A., Connick, W. B., Lachicotte, R. J., Gysling, H. J., & Eisenberg, R. (1998) · Journal of the American Chemical Society · doi:10.1021/ja973216i · Cited by 364
Thioredoxin reductase: Two modes of catalysis have evolved
Williams, C. H., Arscott, L. D., Müller, S., Lennon, B. W., Ludwig, M. L., Wang, P., Veine, D. M., Becker, K., & Schirmer, R. H. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01702.x · Cited by 343
Mitochondria as therapeutic targets for cancer chemotherapy
Galluzzi, L., Larochette, N., Zamzami, N., & Kroemer, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209598 · Cited by 337
Milacic, V., Chen, D., Ronconi, L., Landis-Piwowar, K. R., Fregona, D., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3017 · Cited by 317
Ronconi, L., Marzano, C., Zanello, P., Corsini, M., Miolo, G., Maccà, C., Trevisan, A., & Fregona, D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0509288 · Cited by 314
Arsenite Induces Apoptosis via a Direct Effect on the Mitochondrial Permeability Transition Pore
Larochette, N., Decaudin, D., Jacotot, E., Brenner, C., Marzo, I., Susin, S. A., Zamzami, N., Xie, Z., Reed, J., & Kroemer, G. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4519 · Cited by 301
Targeting Apoptosis Pathways in Cancer Therapy
Fulda, S., & Debatin, K.-M. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332763 · Cited by 290
Role of mitochondrial membrane permeabilization in apoptosis and cancer
Henry-Mowatt, J., Dive, C., Martinou, J.-C., & James, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207534 · Cited by 274
Marcon, G., Carotti, S., Coronnello, M., Messori, L., Mini, E., Orioli, P., Mazzei, T., Cinellu, M. A., & Minghetti, G. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010997w · Cited by 266
Barnard, P. J., Wedlock, L. E., Baker, M. V., Berners‐Price, S. J., Joyce, D. A., Skelton, B. W., & Steer, J. H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200601526 · Cited by 260
Self-citationMcKeage, M. J., Maharaj, L., & Berners-Price, S. J. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00048-6 · Cited by 243
Self-citationPharmacological manipulation of cell death: clinical applications in sight?
Green, D. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26321 · Cited by 242
Weiss, M. J., Wong, J. R., Ha, C. S., Bleday, R., Salem, R. R., Steele, G. D., & Chen, L. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5444 · Cited by 240
Mitochondria: a target for cancer therapy
Armstrong, J. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706556 · Cited by 232
Mustacich, D. J., & Powis, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3460001 · Cited by 231
A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth
Fantin, V. R., Berardi, M. J., Scorrano, L., Korsmeyer, S. J., & Leder, P. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00082-x · Cited by 228
Anticarcinoma Activity in Vivo of Rhodamine 123, a Mitochondrial-Specific Dye
Bernal, S. D., Lampidis, T. J., McIsaac, R. M., & Chen, L. B. (1983) · Science · doi:10.1126/science.6623064 · Cited by 220
Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions
Pia Rigobello, M., Messori, L., Marcon, G., Agostina Cinellu, M., Bragadin, M., Folda, A., Scutari, G., & Bindoli, A. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.04.020 · Cited by 213
Undressing of Phosphine Gold( I ) Complexes as Irreversible Inhibitors of Human Disulfide Reductases
Urig, S., Fritz‐Wolf, K., Réau, R., Herold‐Mende, C., Tóth, K., Davioud‐Charvet, E., & Becker, K. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502756 · Cited by 206
Kidd, J. F., Pilkington, M. F., Schell, M. J., Fogarty, K. E., Skepper, J. N., Taylor, C. W., & Thorn, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106802200 · Cited by 205
Berry, M. J., Kieffer, J. D., Harney, J. W., & Larsen, P. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98657-6 · Cited by 202
Mitochondria: execution central
Gottlieb, R. A. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02010-x · Cited by 198
Thioredoxin: friend or foe in human disease?
Burke-Gaffney, A., Callister, M. E. J., & Nakamura, H. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.06.005 · Cited by 195
Mitochondria, AIF and caspases — rivaling for cell death execution
Penninger, J. M., & Kroemer, G. (2003) · Nature Cell Biology · doi:10.1038/ncb0203-97 · Cited by 194
Wang, Y., He, Q.-Y., Sun, R. W.-Y., Che, C.-M., & Chiu, J.-F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2867 · Cited by 190
Scheffler, I. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00123-5 · Cited by 189
Berners-Price, S. J., & Sadler, P. J. (1988) · Structure and Bonding · doi:10.1007/3-540-50130-4_2 · Cited by 184
Self-citationKOYA, K., Li, Y., Wang, H., Ukai, T., Tatsuta, N., Kawakami, M., Shishido, & Chen, L. B. (1996) · PubMed · Cited by 181
A predictive model for the selective accumulation of chemicals in tumor cells
Trapp, S., & Horobin, R. W. (2005) · European Biophysics Journal · doi:10.1007/s00249-005-0472-1 · Cited by 180
Induction of mitochondrial permeability transition by auranofin, a Gold(I)‐phosphine derivative
Rigobello, M. P., Scutari, G., Boscolo, R., & Bindoli, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704823 · Cited by 178
The role of the mitochondrial permeability transition in cell death
Armstrong, J. S. (2006) · Mitochondrion · doi:10.1016/j.mito.2006.07.006 · Cited by 178
Drugs targeting mitochondrial functions to control tumor cell growth
Dias, N., & Bailly, C. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.03.021 · Cited by 174
Thioredoxin reductase as a novel molecular target for cancer therapy
Nguyen, P., Awwad, R. T., Smart, D. D. K., Spitz, D. R., & Gius, D. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.04.028 · Cited by 172
Hashemy, S. I., Ungerstedt, J. S., Avval, F. Z., & Holmgren, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511373200 · Cited by 162
Rigobello, M. P., Scutari, G., Folda, A., & Bindoli, A. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.09.038 · Cited by 158
Don, A. S., Kisker, O., Dilda, P. J., Donoghue, N., Zhao, X., Decollogne, S., Creighton, B., Flynn, E. A., Folkman, J., & Hogg, P. J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00109-0 · Cited by 156
Distinct Pathways for Stimulation of Cytochrome cRelease by Etoposide
Robertson, J. D., Gogvadze, V. G., Zhivotovsky, B., & Orrenius, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000518200 · Cited by 153
Increased rhodamine 123 uptake by carcinoma cells.
Nadakavukaren, K. K., Nadakavukaren, J. J., & Chen, L. B. (1985) · PubMed · Cited by 147
Mitochondriotoxic compounds for cancer therapy
Fantin, V. R., & Leder, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209599 · Cited by 147
Machida, K., Ohta, Y., & Osada, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513297200 · Cited by 144
Mitochondrial regulation of apoptotic cell death
Gogvadze, V. G., & Orrenius, S. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.04.010 · Cited by 140
Mitochondria as cancer drug targets
Don, A. S., & Hogg, P. J. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.06.005 · Cited by 139
Rigobello, M. P., Callegaro, M. T., Barzon, E., Benetti, M., & Bindoli, A. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00216-5 · Cited by 138
Omata, Y., Folan, M., Shaw, M., Messer, R. L. W., Lockwood, P. E., Hobbs, D. T., Bouillaguet, S., Sano, H., Lewis, J. B., & Wataha, J. C. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.01.012 · Cited by 129
Mitochondrial contributions to cancer cell physiology: potential for drug development
Preston, T. J., Abadi, A., Wilson, A., & Singh, G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00127-2 · Cited by 125
Interaction of Gold(I) with the Active Site of Selenium-Glutathione Peroxidase
Chaudière, J., & Tappel, A. L. (1984) · Journal of Inorganic Biochemistry · doi:10.1016/0162-0134(84)85030-8 · Cited by 119
Rigobello, M. P., Folda, A., Baldoin, M. C., Scutari, G., & Bindoli, A. (2005) · Free Radical Research · doi:10.1080/10715760500135391 · Cited by 107
Wang, Y., He, Q., Che, C., & Chiu, J. (2005) · PROTEOMICS · doi:10.1002/pmic.200402027 · Cited by 87
AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity.
Sun, X., Wong, J. R., Song, K. S., Hu, J., Garlid, K., & Chen, L. B. (1994) · PubMed · Cited by 83
Scholz, C. W., Wieder, T., Stärck, L., Eßmann, F., Schulze‐Osthoff, K., Dörken, B., & Daniel, P. T. (2005) · Oncogene · doi:10.1038/sj.onc.1208233 · Cited by 79
Phosphonium salts exhibiting selective anti-carcinoma activity in vitro.
Rideout, D. C., Calogeropoulou, T., Jaworski, J. S., Dagnino, R., & McCarthy, M. R. (1989) · PubMed · Cited by 77
Gold(III) compound is a novel chemocytotoxic agent for hepatocellular carcinoma
Lum, C. T., Yang, Z. F., Li, G. H., Sun, R. W., Fan, S. T., Poon, R. T. P., Lin, M. C. M., Che, C., & Kung, H. F. (2005) · International Journal of Cancer · doi:10.1002/ijc.21484 · Cited by 77
Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds
Engman, L., McNaughton, M., Gajewska, M., Kumar, S., Birmingham, A., & Powis, G. (2006) · Anti-Cancer Drugs · doi:10.1097/00001813-200606000-00007 · Cited by 54
Smith, P. F., Hoke, G. D., Alberts, D. W., Bugelski, P. J., Lupo, S., Mirabelli, C. K., & Rush, G. F. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23520-0 · Cited by 51
Weisberg, E., KOYA, K., Modica-Napolitano, J. S., Li, Y., & Chen, L. B. (1996) · PubMed · Cited by 48
Caruso, F., Villa, R., Rossi, M., Pettinari, C., Paduano, F., Pennati, M., Daidone, M. G., & Zaffaroni, N. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.11.018 · Cited by 46
Rigobello, M. P., Folda, A., Scutari, G., & Bindoli, A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2005.07.007 · Cited by 41
Gold opens mitochondrial pathways to apoptosis
McKeage, M. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704822 · Cited by 26
Cited by
New trends for metal complexes with anticancer activity
Bruijnincx, P. C., & Sadler, P. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.11.013 · Cited by 1,306
Stable Cyclic Carbenes and Related Species beyond Diaminocarbenes
Melaimi, M., Soleilhavoup, M., & Bertrand, G. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000165 · Cited by 1,066
Coinage Metal−N-Heterocyclic Carbene Complexes
Lin, J. C. Y., Huang, R. T. W., Lee, C. S., Bhattacharyya, A., Hwang, W. S., & Lin, I. J. B. (2009) · Chemical Reviews · doi:10.1021/cr8005153 · Cited by 1,036
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
The Medicinal Applications of Imidazolium Carbene−Metal Complexes
Hindi, K. M., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2009) · Chemical Reviews · doi:10.1021/cr800500u · Cited by 776
Metadata
- Authors
- Barnard, P. J., & Berners-Price, S. J.
- Venue
- Coordination Chemistry Reviews
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 251
- Issue
- 13-14
- Pages
- 1889-1902
- ISSN
- 0010-8545 (ISSN-L)
- OpenAlex
- W2004875516
- Cited by
- 417
- References
- 80
- FWCI
- 13.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.